MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • A Nomogram Model for Predicting Malnutrition among Patients with Parkinson’s Disease

    Q. Huang, X. Zou (Chengdu, China)

  • A non-linear index can detect early postural instability in people with Parkinson’s disease: Enhancing perspectives on the utilization of cost-effective technologies.

    G. Santos, M. D'Alencar, A. Frazão, A. Roque, J. Vivas, M. Piemonte (São Paulo, Brazil)

  • A novel G413S mutation in the CSF1R gene causes Hereditary Diffuse Leucoencephalopathy with axonal Spheroids; clinically overlapping features of Parkinsonism

    ANW. Ullah, MZB. Badshah (Peshawar, Nepal)

  • A Novel Mutation of NKX2-1 Gene: A Rare Presentation of Chorea

    BC. Ari, S. Canbek, G. Kenangil (ISTANBUL, Turkey)

  • A Novel Peer Mentoring Support System for Persons with Parkinson’s Disease

    E. Lubas, TW. Liang, K. Stoveld, SK. Thurman (Philadelphia, USA)

  • A novel single-cell reporter identifies regulators of the endogenous PINK1-Parkin mitochondrial quality control pathway

    J. Thayer, X. Huang, J. Hawrot, D. Ramos, M. Ward, D. Narendra (BETHESDA, USA)

  • A Novel SLC9A1 Mutation Associated with Cerebellar Ataxia and Sensorineural Hearing Loss

    S. Dharmadhikari, Y. Kianirad (Chicago, USA)

  • A pathology-validated study to investigate the role of Uric Acid in Parkinson’s Disease

    P. Pecoraro, S. Carbone, V. Di Lazzaro, L. Di Biase (Rome, Italy)

  • A Patient with Overlapping SPG7 mutation and MERRF

    J. Patino, M. Koenig (Houston, USA)

  • A Phase 1b Randomized, Placebo-Controlled, Delayed-Start Trial of UB-312 in Synucleinopathies.

    P. Millar Vernetti, D. Mirski, JC. Dodart, A. Wood, HJ. Yu, J. Boyd, P. Kundu, R. Setton, D. Silbersweig, E. Stern, C. Lucero, S. Gerrol, H. Kaufmann, J. Martinez (New York, USA)

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley